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Summary
Phenalinolactones are terpene glycosides with anti-
bacterial activity. A striking structural feature is a
highly oxidized g-butyrolactone of elusive biosyn-
thetic origin. To investigate the genetic basis of the
phenalinolactones biosynthesis, we cloned and se-
quenced the corresponding gene cluster from the pro-
ducer strain Streptomyces sp. Tu¨6071. Spanning a 42
kbp region, 35 candidate genes could be assigned to
putatively encode biosynthetic, regulatory, and resis-
tance-conferring functions. Targeted gene inactiva-
tions were carried out to specifically manipulate the
phenalinolactonespathway.The inactivationofasugar
methyltransferase gene and a cytochrome P450 mon-
oxygenase gene led to the production of modified
phenalinolactone derivatives. The inactivation of a
Fe(II)/a-ketoglutarate-dependent dioxygenase gene
disrupted the biosynthetic pathway withing-butyrolac-
tone formation. The structure elucidation of the accu-
mulating intermediate indicated that pyruvate is the
biosynthetic precursor of the g butyrolactone moiety.
Introduction
Streptomycetes continue to be the most prolific source
for bioactive natural products [1]. In the past, research
has been devoted in particular to polyketides and non-
ribosomal-derived peptides, of which many have found
their way to market as indispensable antibiotic drugs.
Yet an unprecedented increase in antimicrobial resis-
tance makes the identification of structurally novel
anti-infectives a demanding task, since new structures
are promising to coincide with new mechanisms of ac-
tion. The most chemically diverse pool of secondary
metabolites in nature is constituted by terpenes [2].
However, the number of terpenoid natural products
identified from Streptomyces is extremely limited. In
*Correspondence: andreas.bechthold@pharmazie.uni-freiburg.de1956, novobiocin was isolated as the first antibiotic
with a terpenoid side chain from Streptomyces niveus
[3], followed by pentalenolactone from Streptomyces
sp. with a pure terpenoid structure [4]. Until now only
around 15 basic structures have been added to this lim-
ited pool, most of them being prenylated rather than pure
terpenoid compounds [5]. Recently, the first biosyn-
thetic gene cluster of an isoprene-derived natural prod-
uct from a Streptomyces strain was reported with the
terpentecin gene locus in Streptomyces griseolospor-
eus strain MF730-N6 [6, 7]. Interestingly, this cluster is
located immediately upstream from the mevalonate
pathway genes for isoprene biosynthesis. It was antici-
pated that this colocalization would efficiently supply
the terpentecin pathway with isoprene building blocks.
MostStreptomyces synthesize terpene natural products
via the nonmevalonate pathway, the alternative route of
isoprene biosynthesis [5]. However, until now there is no
example of nonmevalonate pathway genes being asso-
ciated with a secondary metabolite gene cluster.
Phenalinolactones A–D are terpene glycosides pro-
duced byStreptomyces sp. Tu¨6071 (Figure 1). The strain
was first isolated by Gebhardt and Fiedler in 2001, and
antibacterial activity of the phenalinolactones against
a selection of gram-positive germs was demonstrated
[8]. The structural elucidation was accomplished by
Meyer and Zeeck in 2003, which revealed that the phe-
nalinolactones constitute a unique composition of struc-
tural elements of novelty and biosynthetic interest [9].
The tricyclic anti/anti/syn-configured perhydrophenan-
threne backbone consists of four isoprene units, of
which the fourth comprises the b carbon of an intriguing
g-butyrolactone moiety (Figure 1). This structural ele-
ment can be found in various sesterterpenoids from
marine sponges, like the phospholipase A2 inhibitors
petrosaspongiolides from Petrosaspongia nigra [10].
The masked aldehyde function of the g hydroxybutyro-
lactone was shown to covalently block phospholipase
A2 through the formation of a Schiff base with the N-ter-
minal isoleucine residue [11]. The A ring of the phenali-
nolactones terpenoid scaffold is oxidatively function-
alized, which allows the further decoration with an
L-amicetose and a 5-methylpyrrole-2-carboxylic acid.
The latter was shown to be the key pharmacophore of
the potent gyrase inhibitor clorobiocin from Streptomy-
ces roseochromogenes [12]. Particularly striking is the
oxygen function at C-3, which is further acetylated. Its
presence hints at an epoxidation of the linear terpene
chain prior to its cyclization, analogous to eukaryotic
sterol formation. Although a handful of prokaryotes
have been reported to be capable of sterol production
[13], this would be without precedent for natural product
biosynthesis in bacteria.
Herein, we report the cloning, sequencing, and func-
tional analysis of the phenalinolactones biosynthetic
gene cluster in Streptomyces sp. Tu¨6071. In an effort
to examine details of the phenalinolactones biosynthe-
sis, knockout mutants were generated for a methyltrans-
ferase gene (plaM1), two oxygenase genes (plaO1 and
plaO4), and three genes involved in the formation of
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plaT3). The structure elucidation of derivatives that ac-
cumulated in the mutant strains, together with the anno-
tation analysis of the cluster sequence, leads to a
detailed proposal for major parts of phenalinolactone
biosynthesis.
Results and Discussion
Cloning and Identification of the Gene Cluster
The formation of the deoxyhexose L-amicetose during
phenalinolactone biosynthesis requires the presence of
an NDP-glucose-4,6-dehydratase gene [14]. Therefore
2304Escherichia coliDH5acolonies containing a cosmid
library of the producers genome were screened with
a strain-specific NDP-glucose-4,6-dehydratase gene
probe. Cosmid DNA from 21 positively hybridizing
clones was subsequently analyzed by restriction map-
ping. This revealed that a group of six cosmids contained
overlapping DNA. Fragments derived from this group
were subcloned and sequenced. Guided by restriction
and sequence analysis, two overlapping cosmids,
3-1O12 and 10-4D08, were selected for complete shot-
gun sequencing. From the obtained sequence data,
a contiguous region of 49.4 kbp could be assembled.
The pla gene cluster was assigned to 42 kbp within this
region, with flanking regions of 6.5 kbp upstream and
1 kbp downstream of the clusters assumed boundaries.
The overall G/C content is 70.5 mol %, matching the typ-
ical range of DNA from Streptomyces. Within coding
Figure 1. Chemical Structures of Phenalinolactones
Phenalinolactone A (1) and D (2) are the principal metabolites of
Streptomyces sp. Tu¨6071. The new derivatives PL CD1 (3), PL CD2
(4), and PL CD3 (5) were produced by engineered mutant strains.sections, the G/C frequency is significantly increased at
the codons’ third position, simplifying the identification
of potential ORFs by using the G/C frame plot method
[15]. The annotation analysis revealed 35 candidate
genes putatively encoding biosynthetic, regulatory,
and resistance-conferring functions (Figure 2). The clos-
est homologs of the annotated genes and their proposed
functions are compiled in Table 1.
Genes/Enzymes Putatively Involved
in Terpene Biosynthesis
The genes plaT5 and plaT6 encode proteins that are
highly similar to the nonmevalonate pathway en-
zymes1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate
(HMBPP) synthase and 1-deoxy-D-xylulose-5-phos-
phate (DXP) synthase, respectively. DXP synthase cata-
lyzes the initial step of this pathway: the formation of
DXP by condensation of pyruvate and glyceraldehyde
3-phosphate. HMBPP synthase controls the second-
to-last step in converting 2-C-methyl-D-erythritol-2,
4-cyclodiphosphate into HMBPP [16]. To the best of
our knowledge, this is the first example of nonmevalo-
nate pathway genes being embedded in a secondary
metabolite gene cluster.
The product of plaT4 is most similar to the terpene
synthase ORF1 from the terpentecin producer S. griseo-
losporeus strain MF730-N6. Incubation of purified ORF1
with isopentenyl diphosphate and dimethylallyl diphos-
phate was shown to yield geranylgeranyl diphosphate
(GGDP) [6]. A particularly interesting gene is plaT1,
which encodes a putative monoxygenase with a con-
served FAD binding motif. PlaT1 shows end-to-end
similarities greater than 40% to a multitude of eukaryotic
squalene epoxidases. A recent bioinformatoric ap-
proach identified only two prokaryotic organisms to be
equipped with squalene epoxidase genes [17]. The
product of plaT2 resembles several putative squalene
cyclases. Interestingly, PlaT2 lacks the highly acidic pro-
tonation motif, DxDD, which is proposed to enable the
direct protonation of the terminal double bond of squa-
lene that initiates the cationic cyclization reaction [18].
This motif is also absent in eukaryotic oxidosqualene
cyclases, where prior epoxidation of the substrate facil-
itates the protonation-initiated cyclization. Hence, the
lack of this motif in PlaT2 supports a sterol-like cycliza-
tion reaction within phenalinolactone biosynthesis, as
already indicated through the presence of the putative
epoxidase gene plaT1. The gene plaT3 encodes a pro-
tein homologous to polyprenyltransferases found in as-
sociation with ubiquinone biosynthesis. PlaT3 might be
considered to transfer the phenalinolactones terpene
scaffold on the biosynthetic precursor of the g-butyro-
lactone moiety.
Genes/Enzymes Putatively Involved in Biosynthesis
and Transfer of L-Amicetose
Recently, the rational combination of deoxysugar bio-
synthetic genes from different organisms was success-
fully applied to direct amicetose biosynthesis [19]. In the
phenalinolactone cluster, we describe for the first time
the complete gene set for the formation of this rare de-
oxyhexose. Eight genes can reliably be predicted to en-
code biosynthesis and transfer of this sugar moiety. The
reaction scheme, as can be deduced from the sequence
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367Figure 2. Genetic Organization of the Phenalinolactone Gene Cluster in Streptomyces sp. Tu¨6071
The contiguous sequence derives from two overlapping cosmids, 3-1O12 and 10-4DO8, the boundaries of which are outlined. P = PstI restric-
tion sites.analysis, is congruent with the pathway of L-rhodinose,
the second naturally occurring tridesoxyhexose [20].
L-rhodinose differs from L-amicetose only in the stereo-
configuration at C-4. The multistep conversion of
glucose-1-phosphate to NDP-L-amicetose includes
NDP-D-glucose synthesis (PlaA4), a 4,6-dehydratation
(PlaA3), a 2,3-dehydratation (PlaA2), a 3-ketoreduction
(PlaA5), and a 3-deoxygenation step (PlaA1), to yield
NDP-D-cinerulose. The final steps are 5-epimerization
(PlaA8) and stereospecific 4-ketoreduction (PlaA7)
toward NDP-L-amicetose. Finally, the attachment of
NDP-L-amicetose to O-21 is likely catalyzed by PlaA6,
which resembles many natural product glycosyltrans-
ferases. The candidate enzyme for the further modifica-
tion of the sugar ligand through 4-O-methylation is
PlaM1, with a high degree of sequence identity to
NanM, a putative rhodinosyl-4-O-methyltransferase
from Streptomyces nanchangensis [21].
Genes/Enzymes Putatively Involved in Biosynthesis
and Transfer of 5-Methylpyrrole-2-Carboxylic Acid
A group of four genes was identified (plaP2–plaP5) that
can be assigned to encode biosynthesis and transfer
of the 5-methylpyrrole-2-carboxylic acid. The formation
of this pyrrole ligand has been studied in detail in the
context of clorobiocin biosynthesis in S. roseochromo-
genes [22–24]. The average end-to-end similarity with
the homolog genes from the clorobiocin cluster
(cloN2–cloN6) is almost 80%. Thus, an analog pathway
can be anticipated. However, a major difference is con-
stituted by PlaP4, in which the functions of the free-
standing L-prolyl-AMP-ligase CloN4 and the small pep-
tidyl carrier protein (PCP), CloN5, are combined. CloN4
was shown to convert L-proline into its acyl adenylate
and then transfer the prolyl moiety on the phosphopan-
tetheinyl arm of CloN5. Thus, PlaP4 exhibits the archi-
tecture of a nonribosomal peptide synthetase, with
a C-terminal adenylation (A2) domain and a PCP do-
main located at the N terminus. PlaP3, homologous tothe flavoprotein dehydrogenase CloN3, would catalyze
the four electron oxidation of the PlaP4 bound proline to-
ward the aromatic pyrrolyl-2-carboxy-S-PlaP4 product.
PlaP2 is the homolog of the acyltransferase CloN2,
which was recently shown to be involved in the transfer
of the pyrrole-2-carboxylic acid to 3-OH of the deoxy-
sugar in clorobiocin biosynthesis [24]. Accordingly,
PlaP2 would catalyze the transfer of the pyrrole ligand to
O-20 of the phenalinolactones terpene scaffold. PlaP5
shares conserved sequence motifs with the radical
SAM protein superfamily, and is the homolog of CloN6,
which was shown to methylate C-5 of the pyrrole ligand
[23]. It is interesting to note that the cloN2 mutant of
S. roseochromogenes accumulated only pyrrole-2-car-
boxylic acid, but not its 5-methyl derivative [24]. This in-
dicates that C-5 methylation of the pyrrole ligand does
not occur prior to its transfer to the clorobiocin molecule.
Oxygenase Genes/Enzymes
One Fe(II)/a-ketoglutarate-dependent dioxygenase gene
(plaO1) and four cytochrome P450 monoxygenase
(plaO2–O5) genes can be found within the pla gene clus-
ter. PlaO2–PlaO5 each possess the conserved heme
binding sequence FGxGxHxCLG, with the invariant cys-
teine residue and regions homologous to the O2 binding
motif LLxAGxxS/T [25]. The homologs of the monoxyge-
nases PlaO2, PlaO3, and PlaO5 were shown to hydroxyl-
ate aliphatic carbon atoms, whereas the homolog of
PlaO4 was shown to oxidize a conjugated double
bond, which is part of a polyunsaturated macrolactone
(for references, see Table 1). Thus, we initially assigned
PlaO2, PlaO3, and PlaO5 to the hydroxylations of the
phenalinolactones aliphatic A-ring and PlaO4 to the hy-
droxylation at C-19 of the g-butyrolactone.
The dioxygenase PlaO1 exhibits the characteristic
HxD-signature for the coordination of a-ketoglutarate.
Fe(II)/a-ketoglutarate-dependent dioxygenases partici-
pate in a multitude of biosynthetic reactions coupling
the decarboxylation of a-ketoglutarate to the oxidation
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Protein Amino Acids Homolog ID%/SI% Accession No. Proposed Function Reference
ORF1 228 TrkB (Mycobacterium avium) 58/77 NP_961743.1 K+-transporter
ORF2 222 TrkA (Propionibacterium acnes
KPA171202)
55/72 YP_055767 K+-transporter
ORF3 702 Putative amino acid permease
(Streptomyces avermitilis MA-4680)
83/91 BAC70101 Amino acid transporter
ORF4 447 Putative RNA methyltransferase
(Streptomyces coelicolor A3[2])
80/88 CAA16438 tRNA-5-uracil-
methyltransferase
ORF5 190 Putative transposase (Streptomyces
coelicolor A3[2])
71/80 CAB45597 Transposase
PlaRI 265 MonRI (Streptomyces cinnamonensis)a 83/89 AAO65809 Regulator [29]
PlaR2 200 Putative TetR-family transcriptional
regulator (Streptomyces
coelicolor A3[2])
40/53 CAC44278 Regulator
PlaA1 434 UrdQ (Streptomyces fradiae)a 80/87 AAF72550 3-Deoxygenation [20]
PlaA2 463 LanS (Streptomyces cyanogenus) 61/72 AAD13549 2,3-Dehydratase [44]
PlaA3 323 MtmE (Streptomyces argillaceus) 69/78 T48867 4,6-Dehydratase [45]
PlaA4 301 NanG1 (Streptomyces nanchangensis) 74/85 AAP42866 Nucleotidylyl-transferase [21]
PlaM1 303 NanM (Streptomyces nanchangensis) 61/77 AAP42862 Methyltransferase [21]
PlaP6 321 CloN7 (Streptomyces
roseochromogenes ssp. oscitans)
53/69 AAN65236 Hydrolase [46]
PlaO1 288 TauD (Pseudomonas putida)a 42/59 BAC00965.1 Dioxygenase [47]
PlaT1 449 Squalene epoxidase (Rattus norvegicus)a 23/41 NP_058832.1 Epoxidase [48]
PlaT2 571 Putative squalene cyclase
(Rubrobacter xylanophilus DSM 9941)
31/45 ZP_00200293 Cyclase
PlaT3 337 Putative prenyltransferase
(Rubrobacter xylanophilus DSM 9941)
38/51 ZP_00200292 Prenyltransferase
PlaH 294 BorN (Streptomyces parvulus)a 44/56 CAE45678 2-Hydroxyhept-2,4-diene-
1,7-dioate isomerase
[32]
PlaO2 397 EncR (Streptomyces maritimus)a 40/54 AAF81737 Cytochrome P450
monoxygenase
[49]
PlaM2 281 Putative rRNA-methyltransferase
(Streptomyces coelicolor A3[2])
54/67 NP_628799 Self-resistance
PlaO3 401 EryK (Aeromicrobium erythreum)a 47/63 AAU93795 Cytochrome P450
monoxygenase
[50]
PlaP1 96 CloN1 (Streptomyces roseochromogenes
ssp. oscitans)
57/65 AAN65230 Hypothetical protein [46]
PlaP2 355 CloN2 (Streptomyces roseochromogenes
ssp. oscitans)a
68/81 AAN65231 Acyltransferase [24]
PlaP3 377 CloN3 (Streptomyces roseochromogenes
ssp. oscitans)a
70/81 AAN65232 Dehydrogenase [22]
PlaP4 594 CloN4 aa 1–498a 68/78 AAN65233 Acyl-CoA synthetase [22]
CloN5 aa 507–594 (Streptomyces
roseochromogenes ssp. oscitans)a
61/76 AAN65234 Peptidyl-carrier protein [22]
PlaP5 568 CloN6 (Streptomyces roseochromogenes
ssp. oscitans)a
81/90 AAN65235 Methyltransferase [46]
PlaT4 359 GGDPS (Kitasatospora griseola)a 46/59 BAB07816 GGDP synthase [6]
PlaT5 386 GcpE (Mycobacterium avium) 73/84 NP_961872 HMBPP synthase
PlaT6 593 DXS (Kitasatospora griseola) 55/66 BAB20589 DXP synthase
PlaU 244 ChnA (Brevibacterium epidermidis
sp. HCU)a
41/53 AAK73164 Dehydrogenase [33]
PlaV 484 EstB (Burkholderia gladioli)a 29/42 AAF59826 Self-resistance [31]
PlaO4 391 PimD (Streptomyces natalensis)a 41/55 CAC20932 Cytochrome P450
monoxygenase
[25]
PlaA5 335 Gra-orf26 (Streptomyces violaceoruber)a 55/66 CAA09647 3-Ketoreductase [51]
PlaA6 396 MtmGIII (Streptomyces argillaceus) 35/51 AAD55583 Glycosyl-transferase [52]
PlaA7 311 TylCIV (Streptomyces fradiae) 50/63 AAD41822 4-Ketoreductase [53]
PlaA8 191 LndZ1 (Streptomyces globisporus) 53/69 AAT37542 3,5-Epimerase
PlaO5 409 PicK (Streptomyces venezuela)a 43/56 AAC64105 Cytochrome P450
monoxygenase
[54]
PlaM3 270 Putative rRNA-methyltransferases
(Streptomyces coelicolor A3[2])
50/63 NP_628799 Self-resistance
PlaR3 119 Putative transcriptional regulator
(Nocardia farcinica IFM 10152)
55/71 YP_117420 Regulator
PlaZ 237 Putative short-chain dehydrogenase
(Rhizobium leguminosarum)
38/54 AAL14912 Dehydrogenase
ORF6 311b AnsG oxidoreductase
(Streptomyces collinus)
40/51 AAD31836 Oxidoreductase [55]
a Function experimentally established.
borf incomplete.
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369Figure 3. Labeling of the Diterpene Scaffold of 2 from D-[1-13C]glucose Feeding
Phenalinolactone D (2) was isolated from liquid cultures of Streptomyces sp. Tu¨6071 supplied with D-[1-13C]glucose. The labeling pattern ob-
served in the terpene scaffold of 2 documents that the IPP units are synthesized via the nomevalonate pathway (a) and not via the acetate-
mevalonate pathway (b). Asterisk indicates 13C atoms.of carbon atoms [26]. A prominent example for the ver-
satility of this class of enzymes is the clavaminate syn-
thase, which catalyzes three separate oxidative steps
in the biosynthesis of clavulanic acid [27]. The reactions
comprise hydroxylation, dehydration, and oxidative cy-
clization. All these types of reaction can be assumed to
occur during the formation of the phenalinolactones
g-butyrolactone moiety.
Genes/Enzymes Putatively Involved in Regulation
and Self-Resistance
Located at the 50-end of the cluster is plaR1, which en-
codes a protein with high end-to-end similarity to regu-
latory proteins from the SARP family [28]. SARPs inter-
act with characteristic heptameric tandem repeat
sequences upstream of biosynthetic genes to activate
transcription. The OmpR-like helix-turn-helix consensus
motif for DNA binding, strongly conserved in members
of the SARP family, is present in PlaR1. A potential
DNA binding site (TCGAGCG-N12-TCGAGCG) could be
found upstream of plaA5. The closest homolog is the ac-
tivator MonRI from Streptomyces cinnamonensis, which
was shown to significantly increase monensin produc-
tion after overexpression [29]. Downstream follows
plaR2, which encodes another putative transcriptional
regulator homologous to the TetR family. To the same
family belongs the gene product of plaR3, the third puta-
tive regulatory gene, which is located almost at the 30
end of the cluster.
Three genes (plaM2, plaM3, and plaV) can be consid-
ered to confer phenalinolactone resistance to the pro-
ducing organism. PlaM1 and PlaM2 resemble rRNA-
methyltransferases, which are common resistance
determinants in antibiotic producers. They prevent the
binding of the antibiotic to the ribosome by methylating
its specific target site [30]. This would indicate that the
phenalinolactones interfere with protein biosynthesis.
An additional resistance mechanism might be estab-
lished by plaV, which encodes a putative hydrolase.
Among a multitude of b-lactamases, PlaV is similar to
the hydrolase EstB from Burkholderia gladioli, which
adopts a b-lactamase fold but has esterolytic activity.
It was shown that EstB deacetylates 7-aminocephalo-
sporinic acid [31]. Three ester functions in the phenali-
nolactones structure can be considered as target for
PlaV. In particular, ester hydrolysis of the g-butyrolac-tone or cleavage of the pyrrole carboxylic ester, both
known to be crucial pharmacophores in other com-
pounds, would likely be accompanied by the loss of
the phenalinolactones biological activity.
Other Genes/Enzymes
The product of plaH shows homology to 2-hydroxy-
hepta-2,4-diene-1,7-dioate isomerase (HHDI), a key
enzyme of the tyrosine catabolism via the 4-hydroxy-
phenylacetic acid pathway. HHDI catalyzes the tauto-
merization of 2-hydroxyhepta-2,4-diene-1,7-dioate to
2-oxohepta-3-ene-1,7-dioate. For the closest homolog,
BorN from the borrelidin producer, Streptomyces parvu-
lus Tu¨4055, it was suggested that the enzyme diverges
2-oxohepta-3-ene-1,7-dioate from primary metabolism
to borrelidin biosynthesis. This channeling function
was corroborated through inactivation of borN, which
led to a decreased, but not abolished, borrelidin produc-
tion [32]. The products of plaU andplaZ both contain do-
mains of short-chain dehydrogenases (Pfam00106) and
enoyl-[acyl carrier protein] reductases (COG0623). The
closest homolog of PlaU is the dehydrogenase, ChnA,
which is involved in the oxidative degradation of cyclo-
hexanol. ChnA catalyzes the dehydrogenation of cyclo-
hexanol toward cyclohexanone [33]. Finally, plaP1 and
plaP6 encode the homologs of the hypothetical protein,
CloN1, and the putative hydrolase, CloN7, from S. rose-
ochromogenes, respectively. cloN1 and cloN7 are lo-
cated within the operon for pyrrole-2-carboxylic acid
biosynthesis, but their functions have not yet been es-
tablished.
Isotope Feeding
The presence of the plaT5 and plaT6 genes implies that
the phenalinolactones isoprene building blocks are syn-
thesized via the nonmevalonate pathway. To confirm
this, we fed D-[1-13C]glucose to cultures of Streptomy-
ces sp. Tu¨6071. The catabolism of D-[1-13C]glucose via
glycolysis yields [3-13C]glyceraldehyde-3-phosphate
(GAP) and [3-13C]pyruvate, the starting material for the
nonmevalonate pathway (Figure 3). The latter yields
[2-13C]acetate after decarboxylation. [3-13C]GAP and
[3-13C]pyruvate enter the nonmevalonate pathway, giv-
ing rise to isoprene (IPP) monomers labeled at carbons
1 and 5 [34]. The alternative acetate-mevalonate route
would utilize [2-13C]acetate, leading to [2,4,5-13C3]IPP
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analysis of compound 2 (Figure 1) isolated from the
D-[1-13C]glucose feeding showed that, within the ter-
pene scaffold, carbons 2 (5.0), 6 (4.9), 11 (5.2), 15 (3.4),
21 (3.8), 22 (4.9), 23 (5.1), and 24 (4.9) were enriched (rel-
ative enrichments in parentheses). This matches the
expected labeling pattern that arises from [1,5-13C2]IPP
units. Hence, we can document that the phenalinolac-
tones terpene scaffold comprises four isoprene mono-
mers supplied via the nonmevalonate pathway.
Generation of Mutant Strains
In order to document the involvement of the pla gene
cluster in phenalinolactone biosynthesis, we sought
the rational design of a novel phenalinolactone deriva-
tive by targeted gene inactivation. A promising candi-
date for this approach was the putative sugar methyl-
transferase gene, plaM1. Inactivation of this class of
genes has successfully been applied to generate novel
derivatives in other systems [35, 36]. Further gene inac-
tivations were carried out to gain insight into the forma-
tion of the phenalinolactones core structure, including
the striking g-butyrolactone moiety. Therefore, we se-
lected genes that we assumed to be involved in the
assembly of the terpene backbone (plaT1, plaT2) and
in the biosynthesis of the g-butyrolactone (plaT3,
plaO1, plaO4). The mutations were achieved either by
deletion of an internal fragment (plaM1, plaO1, plaO4,
plaT1) or by a shift of the reading frame (plaT1,plaT2). In-
activation plasmids were introduced into the wild-type’
s chromosome by means of homologous recombina-
tion. The single- and double-crossover recombination
events were documented by PCR analysis. All mutant
strains were subsequently complemented in trans with
a full-length copy of the respective gene under control
of the constitutive promoter, ermE*. This restored wild-
type production to full levels in all mutant strains (for de-
tailed protocols for the generation of inactivation and
complementation plasmids, and for PCR analysis, see
the Supplemental Data available online).
Inactivation of plaM1
The production profile of the mutant strain Streptomy-
ces sp. Tu¨6071 DplaM1 was analyzed by HPLC/electro-
spray ionization (ESI)-MS at a detection wavelength of
l = 280 nm and compared to that of the wild-type. The
wild-type produced phenalinolactones A and D as
major metabolites with retention times (RT) of 21.4 and
24.5 min and molecular ions of m/z 714 [M-H]2 and
m/z 698 [M-H]2, respectively (1 and 2, Figure 4). Both
were absent in the mutant, which instead produced
a novel main compound at RT = 21.8 min, with the typical
UV/VIS spectrum of the phenalinolactones chromo-
phore, referred to as PL CD1 (3, Figure 4). The corre-
sponding molecular ion of m/z 684 [M-H]2 reflected
a mass difference of 14 amu in reference to 2, consistent
with the envisaged loss of a methyl group. To locate the
position of the missing methyl group, 3 was purified from
an upscaled fermentation and subjected to 1H-NMR
spectroscopy. As expected, the distinct methoxy singlet
of the 40 0-O-CH3 group at d 3.51 was absent in the
1H-spectrum of 3. Thus, 3 lacking the sugar methyl
group was clearly identified as the progenitor of 2. This
result documents that PlaM1 is an L-amicetosyl-40 0-O-methyltransferase and thereby unambiguously proves
that the cloned gene cluster encodes phenalinolactone
biosynthesis. Interestingly, an unmethylated variant of
1, the wild-types main derivative, was observed in the
mutant only in traces (data not shown). This implies
that hydroxylation at C-1 occurs after methylation of
the sugar ligand, since the involved oxygenase seems
to be inefficient in utilizing 3 as substrate.
Inactivation of plaT1, plaT2, and plaT3
The analysis of the mutants’ extracts by HPLC/ESI-MS
revealed that, in all cases, phenalinolactone production
was abolished completely, without leading to the accu-
mulation of any detectable intermediates. This under-
lines that PlaT1, PlaT2, and PlaT3 are essential for phe-
nalinolactone formation, but their respective functions
remain to be resolved.
Inactivation of plaO4 and plaO1
The HPLC/ESI-MS analysis of the mutant strain Strepto-
myces sp. Tu¨6071DplaO4 revealed two novel main com-
pounds at RT = 18.3 and 21.4 min labeled as PL CD2 and
PL CD3, respectively (4 and 5, Figure 4). In both com-
pounds the characteristic UV/VIS-spectrum of the phe-
nalinolactones was precisely conserved. The corre-
sponding molecular masses were determined with m/z
512 [M-H]2 for 4 and m/z 554 [M-H]2 for 5. To elucidate
the underlying structure, 4 was purified from an up-
scaled fermentation and subjected to 1D (1H, 13C) and
2D (1H-1H-COSY, HSQC, HMBC) NMR spectroscopy.
The analysis of the 1H and 13C spectra revealed the ab-
sence of the signals for the sugar and the acetyl moi-
ety. Instead, a novel signal corresponding to a methyl
group showed up in the 1H spectrum at d 0.79. 3J cor-
relations to C-3, C-5, and C-20, and a 2J correlation to
C-4, observed in the HMBC spectrum clearly identified
this novel methyl group to be linked to the quaternary
carbon at C-4. The chemical shift of the corresponding
carbon signal at d 12.9 documents the axial position of
this methyl group [37]. This explains the lack of the
sugar signals, since this methyl group needs to un-
dergo oxidation first, before the O-glycosidic sugar
transfer can take place. Other than expected, the
structure of 4 (Figure 1) identified PlaO4 to be the oxy-
genase that hydroxylates C-21 during phenalinol-
actone biosynthesis. The mass difference of 42 amu
suggests that 5 (Figure 1) is the 3-O-acetylated conge-
ner of 4.
Upon HPLC/ESI-MS analysis of the mutant Strepto-
myces sp. Tu¨6071 DplaO1 at a detection wavelength of
l = 235 nm two novel compounds, now referred to as
PL CD6 and PL CD7 (6 and 7, Figure 4), could be de-
tected at RT = 18.1 min and RT = 20.2 min with molecular
ions ofm/z 373 [M-H]2 andm/z 371 [M-H]2, respectively
(Figure 4, A). Both compounds displayed the same UV/
VIS spectrum which differed fundamentally from that
of the phenalinolactones chromophore (Figure 4, B).
An intense tailing of the corresponding peaks in the re-
versed-phase chromatography suggested the presence
of an acidic function. For structure elucidation, both de-
rivatives were purified from an upscaled fermentation
and subsequently submitted to high-resolution ESI-MS.
The observed molecular ions were m/z 373.2384 [M-H]2
for 6 and m/z 371.2233 [M-H]2 for 7, indicating sum
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(A) HPLC traces of crude extracts of Streptomyces sp. Tu¨6071 (wt) and its mutant strains Streptomyces sp. Tu¨6071 DplaM1 (DplaM1), Strep-
tomyces sp. Tu¨6071 DplaO4 (DplaO4), and Streptomyces sp. Tu¨6071 DplaO1 (DplaO1).
(B) UV/VIS spectra of the respective main metabolites.formulae of C23H33O4 [M-H]
2 (calculated: m/z 373.2379)
and C23H31O4 [M-H]
2 (calculated: m/z 371.2222), re-
spectively. The mass difference of Dm = 2.0157 amu,
matching the mass of two protons, suggested that 6
and 7 constitute a redox pair of a common basic struc-
ture.
The subsequent NMR analyses identified 6 as the al-
most unmodified diterpenoid core of the phenalinolac-
tones extended with a C4 side chain attached to C-14
(Figure 5). The signals of the methyl groups at C-19,
C-20, C-21, C-22, and C-23 could be assigned based on
their respective 3J correlations to the core carbon atoms
observed in the HMBC spectrum. The characteristic sig-
nals of the g-butyrolactone portion were absent. In-
stead, proton signals of a novel double bond appeared.
The transconfiguration of this double bond was reflected
in the coupling constant value of 3JH15–H16 = 16 Hz. Theplacement of this olefin in 6 was ascertained through
correlation from H-15 to H-14 observed in the 1H1H-
COSY, with 3JH15–H14 = 11 Hz. The observation of the
13C-NMR spectrum at low temperature (248K) allowed
the detection of two carbon signals at d 168.5 (C18) and
d 191.0 (C17), correlating to a carboxylic acid and a ke-
tone, respectively. Long-range correlations 3JH14–C16,
3JH15–C17,
2JH16–C17, and
3JH16–C18 established the partial
structure of a b,g-unsaturated a-keto acid linked to C-14.
The presence of the OH function at C-3 was reflected in
the chemical shift of d 3.13 for H-3, consistent with its at-
tachment to a carbon bearing a heteroatom. The axial
position of H-3 could be determined due to the coupling
constant values of 11 Hz and 5 Hz, indicating an axial-
axial and an axial-equatorial coupling to Hax-2 and
Heq-2, respectively. Thus, 3-OH is in equatorial position
as it is the 3-O-acetyl substituent in 1. A furtherFigure 5. Structure Elucidation of PL CD6
and PL CD7
Single-headed arrows indicate 3JHC long-
range couplings observed by HMBC experi-
ments, double-headed arrows represent
3JHH couplings observed in the
1H/1H-COSY
spectrum. Crucial 3JHH coupling constants
are specified. 6, PL CD6; 7, PL CD7.
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appears as an unresolved broad multiplett due to two
allylic couplings to H-22 and H-14, respectively, and
a 3J-coupling to H-11.
The structure of the side chain observed in PL CD6
suggests that the biosynthetic precursor of the g-butyr-
olactone is phosphoenolpyruvate, which gets attached
to C-15 of the terpene backbone. The initial assumption,
that 7 is the oxidized variant of 6, was clearly confirmed
by 1H and 1H/1H-COSY analysis of 7: the absence of
the H-3 signal documents the oxidation of the secondary
alcohol at C-3 toward the keto function (Figure 5). This is
further reflected in the low field shift of the neighbored
H-2a/b methylene signal from d1.60 in 6 toward d2.49 in 7.Model for Phenalinolactone Biosynthesis
The functional analysis of the pla gene cluster combined
with the results from the structure elucidation of phena-
linolactone intermediates allows a substantial proposal
for the biosynthesis of 1, as depicted in Figure 6.
The pathway falls into the major parts of (1) terpene
backbone formation and its extension with phospho-
enolpyruvate, (2) modification and rearrangement of
the phosphoenolpyruvate-derived side chain toward
the g-butyrolactone moiety, (3) biosynthesis of L-amice-
tose and pyrrole-2-carboxylic acid, and (4) group trans-
fer reactions and late-step tailoring.
Based on sequence analysis, PlaT1–T6 comprise
the enzymatic machinery to biosynthesize the
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373phenalinolactones scaffold, as represented in the struc-
ture of 6. Feeding of D-[1-13C]glucose to cultures of
Streptomyces sp. Tu¨6071 clearly demonstrated that
the isoprene building blocks for phenalinolactone bio-
synthesis derive from the nonmevalonate pathway. As
all actinomycetes are equipped with the nonmevalonate
pathway for isoprene production during primary metab-
olism [5], it is tempting to speculate why additional cop-
ies of the dxp and hmbpp synthase genes are located
within the pla gene cluster. For the DXP synthase,
a rate-limiting role in the nonmevalonate pathway could
be suggested based on both assessment of its catalytic
efficiency and the increased level of terpenoid produc-
tion after overexpression [38]. Interestingly, the same
immediate proximity of the dxp and the hmbpp synthase
genes observed in the pla gene cluster is also present in
the genomes of Streptomyces coelicolor and Strepto-
myces avermitilis, where the hmbpp synthase genes
are located directly upstream of the dxp synthase genes
as well. This conserved colocalization hints on a syner-
gistic effect of both functions, potentially capable of
enhancing isoprene production.
The GGDP synthase homolog PlaT4 would catalyze
the consecutive head-to-tail condensations of four iso-
prene monomers toward GGDP, the phenalinolactones
direct terpene precursor. The phenalinolactones hy-
droxyl function at C-3, which occurs at the equivalent
position in eukaryotic sterols, and the presence of the
squalene epoxidase homolog, PlaT1, suggest an epox-
idation of the C-14/-15 double bond of GGDP prior to
its cyclization. Indirect support for such a mechanism
is 2-fold. First, the hydroxyl group at C-3 is already
present in 6, an intermediate whose structure seems
to represent the stage in phenalinolactone formation
immediately after the cyclization reaction. Second,
the cyclase PlaT2 lacks the protonation motif DXDD,
which would be essential for the direct protonation of
the C-14/-15 double bond of GGDP without prior epox-
idation [18].
The fact that the plaO1 mutant produced, in addition
to 6, its 3-keto analog, 7, raises the question whether
an epimerization at C-3 takes place during this early
stage of phenalinolactone biosynthesis. It may be spec-
ulated that the hydroxyl at C-3 emanates from the epox-
ide, primarily in the axial configuration. An epimerase
would then oxidize C-3, yielding 7, and then reduce the
resulting ketone from the opposite face of the molecule,
yielding 6. This mode of direct epimerization was inten-
sively studied for UDP-galactose-4-epimerases [39].
However, it can not be excluded that 7 is a shunt metab-
olite, emanating from accumulating 6 by the action of an
unspecific dehydrogenase from outside the pla gene
cluster.
The structure of the C4 side chain observed in 6 sug-
gests that pyruvate is the g-butyrolactones precursor
unit. The prenyltransferase homolog PlaT3 might be
considered for the transfer of phosphoenolpyruvate
to the terpene backbone, but it remains elusive
whether this extension occurs before or after the cycli-
zation reaction. As the next step, the dehydrogenation
of the newly established C-C linkage would follow,
giving the C-15/C-16 double bond. A candidate dehy-
drogenase for this reaction is encoded by plaZ. The
subsequent hydroxylation of this double bond, result-ing in the enol function at C-19, is likely to be catalyzed
by the dioxygenase PlaO1, as indicated by the accu-
mulation of the nonhydroxylated 6 in the plaO1 mutant.
Further steps toward the g-butyrolactone portion re-
main very speculative. One potential route might be ini-
tiated by an intramolecular nucleophilic attack of C-15
on C-17, resulting in a cylopropanone intermediate.
Ring opening would then yield the branched side chain
with an aldehyde and an a-keto acid. Tautomerization
of the a-keto group to the enol, potentially catalyzed
by the isomerase PlaH, would be followed by the ring
closure via hemi-acylal formation toward the g-butyro-
lactone.
The molecular prerequisite for the decoration with the
pyrrole and the sugar ligand is the oxidation of both
methyl groups that are linked to the prochiral center at
C-4. We could demonstrate that PlaO4 is responsible
for the hydroxylation of the axial methyl group. Candi-
dates for the hydroxylation of the equatorial methyl
group are the remaining cytochrome P450 monoxyge-
nases PlaO2, PlaO3, and PlaO5.
The final assembly of the phenalinolactones com-
prises the transfer of the pyrrole substituent to O-20,
the O-glycosidic linkage of the L-amicetose to O-21,
and the acetylation of O-3. The pyrrolyl and glycosyl
transfer are presumably catalyzed by the putative acyl-
transferase PlaP2 and the putative glycosyltransferase
PlaA6, respectively. However, for the acetyl transfer,
no convincing candidate gene could be assigned;
thus, it seems that the involved transferase is encoded
from outside the pla gene cluster. The C-methylation
at C-5 of the pyrrole moiety and the methylation of O-4
of the L-amicetose, catalyzed by PlaM1 and PlaP5, re-
spectively, are regarded to be the last steps toward
the biosynthesis of 2. Finally, 2 gets converted to 1
through hydroxylation of C-1 by one of the cytochrome
P450 monoxygenases (PlaO2, PlaO3, or PlaO5).
Significance
Phenalinolactones are novel tricyclic terpene metabo-
lites from Streptomyces sp. Tu¨6071 with antibacterial
activity. They exhibit a striking composition of struc-
tural elements of biosynthetic interest. With the char-
acterization of the pla gene locus, we report here
only the second biosynthetic gene cluster of a terpene
natural product from Streptomyces, and the first one
containing nonmevalonate pathway genes for iso-
prene biosynthesis. The functional analysis of the
cluster, based on sequence comparison and gene in-
activations, enabled us to propose a substantial model
for the phenalinolactones biosynthetic pathway.
We demonstrate that this pathway can be genetically
manipulated to direct the generation of novel deriva-
tives. This sets the basis for future studies on the en-
gineering of more potent phenalinolactone analogs
through combinatorial biosynthesis. The structure
elucidation of an early-stage intermediate, which was
isolated from a dioxygenase-deficient mutant strain,
revealed that the g-butyrolactone emanates from a C4
side chain, which presumably derives from the attach-
ment of phosphoenolpyruvate to the terpene back-
bone.
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Construction and Screening of a Streptomyces sp. Tu¨6071
Genomic Cosmid Library
DNA manipulations were performed according to standard proce-
dures for E. coli [40] and Streptomyces [41]. A Streptomyces sp.
Tu¨6071 genomic cosmid library was constructed in E. coli DH5a.
For DNA extraction, mycelium was embedded in agarose, then the
DNA was partially digested with Sau3AI and isolated, yielding frag-
ments with an average size greater than 35 kbp. The fragments
were ligated into cosmid pOJ436 digested with BamHI and in vi-
tro-packaged with the Gigapack III Gold packaging extract kit ac-
cording to the manufacturer’ s handbook (Stratagene). Robotically
produced high-density colony arrays (Hybond-N+; Amersham Phar-
macia) were utilized for the screening of 2304 cosmid clones with
a strain-specific NDP-glucose-4,6-dehydratase gene probe follow-
ing standard hybridization procedures. The gene probe was ampli-
fied with the oligonucleotide primers 50-CSGGSGSSGCSGGSTT
CATSGG-30 (forward) and 50-GGGWRCTGGYRSGGSCCGTAGTTG-30
(reverse) by using genomic DNA from Streptomyce sp. Tu¨6071 as
template (abbreviations according to standard IUPAC nomenclature
for degenerate nucleotides).
Sequencing of the pla Gene Cluster
Cosmids 3-1O12 and 10-4D08 were sequenced by shotgun se-
quencing of a subclone library for each cosmid, consisting of 1.5–
2.0 kbp fragments (obtained through shearing with a nebulizer) in
pCR4blunt-TOPO (Invitrogen). DNA sequencing was carried out
with an ABI Prism 3100 automated sequencer (Applied Biosystems).
The raw sequence data were processed and assembled with the
phred/phrap/consed software package (www.phrap.org). The anno-
tation analysis of the sequence data was performed through data-
base comparison with the BLAST search tools on the server of the
National Center for Biotechnology Information, Bethesda, Maryland
[42]. The sequence data reported here have been deposited in the
GenBank database under the accession number DQ230532.
Culture Conditions
Streptomyces sp. Tu¨6071 was grown in NL111V liquid medium (2%
lab lemco meat powder, 1% CaCO3, 10% malt extract, pH adjusted
to 7.2) dispensed in double-baffled flasks. The cultures were main-
tained at 28ºC and 180 rpm on a rotary incubator and harvested after
6–8 days. E. coli strains XL 1 blue and ET12567 were cultured in
LB medium at 37ºC with the appropriate antibiotic selection at a
final concentration of 100 mg ml21 carbenicillin and 35 mg ml21
apramycin.
Analysis of Phenalinolactone Production
and Isolation of Derivatives
To assess phenalinolactone production of Streptomyces sp. Tu¨6071
wild-type and its mutants, 20 ml NL111V liquid media was inoculated
from a sporulated plate culture and grown as described above. After
8 days, a 1 ml aliquot of the culture was extracted with 1 ml of ethyl
acetate. The organic phase was evaporated to dryness with
a Speed-Vac. The residue was redissolved in 200 ml DMSO 50%
and clarified by centrifugation. HPLC/MS analysis was performed
on an Agilent 1100 series system by ESI. The HPLC system was
equipped with an Agilent ZORBAX SB C-18 column (5 mm particle
size, 4.6 3 150 mm), maintained at 35ºC. Detection wavelength
range of the diode array was set to 200–500 nm. The gradient profile
consisted of solvent A (0.5% acetic acid in H2O) and solvent B (0.5%
acetic acid in CH3CN). An initial hold for 3 min with 30% B was fol-
lowed by a linear gradient with 35% B after 9 min, 60% B after
16 min, 85% B after 19 min, 95% B after 23 min, and held at 95%
B for a further 7 min. The solvent flow rate was 0.7 ml min21.
For an upscaled phenalinolactone production, 1 liter NL111V liq-
uid medium was equally dispensed into three 2 liter double-baffled
Erlenmeyer flasks and inoculated with 3-day-old seed cultures.
The cultures were agitated at 28ºC and 150 rpm. After 7 days, the fer-
mentation was centrifuged to separate mycelia from the aqueous
phase. The latter was extracted three times with equal volumes of
ethyl acetate. The organic phase was dried, yielding from 200 to
400 mg crude extract. The crude extract was then adsorbed into
a solid-phase extraction cartridge (SepPak C18; Waters Associates)and fractionated with a water/methanol gradient. Fractions contain-
ing phenalinolactone derivatives were pooled and applied for further
isolation on an Agilent 1100 system with a semipreparative Zorbax
Eclipse XDB-C18 column (5 mm particle size, 9.4 mm 3 150 mm) uti-
lizing mass guided-fraction collection. Phenalinolactone derivatives
were yielded in the range of 1–2 mg per 1 liter fermentation broth.
Structure Elucidation
High-resolution ESI (HRESI) mass spectra were acquired with a Mi-
cromass QTOF2 mass spectrometer. NMR spectra were recorded at
a 1H resonance frequency of 500 MHz (Bruker DRX 500) and 400 MHz
(Bruker DRX 400). Standard parameters were used for 1D and 2D
NMR spectra, which included 1H, 13C, 1H/1H-correlated spectros-
copy (COSY), heteronuclear single-quantum coherence (HSQC),
and heteronuclear multiple-bond correlation (HMBC). All chemical
shifts were referenced to residual CHCl3 (2, 3) and MeOH (4, 6, 7),
respectively.
Phenalinolactone D (2)
1H NMR (CDCl3) d (multiplicity, assignment): 0.98 (s, H24); 1.08 (s,
H1a); 1.10 (m, H7a); 1.12 (m, H9); 1.17 (s, H22); 1.24 (d, H60 0); 1.30
(brd, H5); 1.58–1.72 (m, H2a); 1.58–1.72 (m, H2b); 1.62 (brs, H23);
1.67 (m, H7b); 1.72 (m, H20 0a); 1.72–1.85 (m, H30 0a); 1.72–1.85 (m,
H30 0b); 1.77 (m, H6a); 1.87 (m, H1b); 1.87 (m, H6b); 1.89 (m, H20 0b);
2.04 (s, H26); 2.09 (m, H11b); 2.30 (m, H11a); 2.33 (brs, H60); 3.01
(ddd, H40 0); 3.41 (brs, H14); 3.41 (d, H21b); 3.51 (s, H70 0); 3.84 (d,
H20b); 3.89 (dq, H50 0); 4.42 (d, H21a); 4.83 (d, H20a); 4.62 (d, H10 0);
5.04 (dd, H3); 5.53 (brs, H12); 5.86 (d, H16); 5.97 (dd, H40); 6.85 (dd,
H30); 7.15 (d, 16-OH); 9.03 (brs, NH); 13C NMR (CDCl3) d: 13.2 (C60);
14.3 (C24); 17.7 (C60 0); 20.7 (C6); 21.3 (C26); 22.1 (C23); 23.1 (C11);
23,4 (C2); 23.8 (C30 0); 27.6 (C22); 29.3 (C20 0); 38,2 (C1); 38.4 (C10);
39.2 (C8); 40.2 (C14); 40.5 (C7); 45.1 (C4); 49.1 (C5); 54.7 (C9); 56.7
(C70 0); 62.6 (C20); 68.6 (C50 0); 68.8 (C21); 73.9 (C3); 81.6 (C40 0); 98.1
(C10 0); 98.5 (C16); 109.1(C40); 116.6 (C30); 120.9 (C20); 122.2 (C12);
129.8 (C15); 132.4 (C13); 134.1 (C50); 138.8 (C19); 160.3 (C10); 169.1
(C18); 170.5 (C25).
Phenalinolactone CD1 (3)
1H NMR (CDCl3) d (multiplicity, assignment): 0.98 (s, H24); 1.09 (s,
H1a); 1.10 (m, H7a); 1.10 (m, H9); 1.18 (s, H22); 1.26 (d, H60 0); 1.30
(brd, H5); 1.58–1.72 (m, H2a); 1.58–1.72 (m, H2b); 1.62 (brs, H23);
1.72–1.85 (m, H30 0a); 1.72–1.85 (m, H30 0b); 1.75 (m, H20 0a); 1.78 (m,
H7b); 1.80 (m, H6a); 1.87 (m, H1b); 1.90 (m, H20 0b); 1.90 (m, H6b);
2.04 (s, H26); 2.05 (m, H11b); 2.28 (m, H11a); 2.33 (brs, H60); 3.40
(brs, H14); 3.41 (d, H21b); 3.48 (ddd, H40 0); 3.85 (d, H20b); 3.86 (dq,
H50 0); 4.42 (d, H21a); 4.84 (d, H20a); 4.62 (d, H10 0); 5.03 (dd, H3);
5.54 (brs, H12); 5.93 (s, H16); 5.97 (dd, H40); 6.85 (dd, H30); 9.03
(brs, NH); 13C NMR (CDCl3) d: 13.2 (C6
0); 14.3 (C24); 17.6 (C60 0);
20.7 (C6); 21.3 (C26); 22.1 (C23); 23.1 (C11); 23.4 (C2); 27.6 (C22);
28.1 (C30 0); 29.7 (C20 0); 38.3 (C1); 38.4 (C10); 39.2 (C8); 40.3 (C14);
40.5 (C7); 45.1 (C4); 49.1 (C5); 54.7 (C9); 62.7 (C20); 68.9 (C21); 69.5
(C50 0);72.8 (C40 0); 73.9 (C3); 98.2 (C10 0); 98.6 (C16); 109.1(C40); 116.7
(C30); 120.9 (C20); 122.3 (C12); 130.0 (C15); 132.3 (C13); 134.1 (C50);
139.0 (C19); 160.4 (C10); 169.1 (C18); 170.5 (C25).
Phenalinolactone CD2 (4)
1H NMR (CD3OD) d (multiplicity, assignment, coupling constants,
HMBCs [* indicates indirectly observed via HSQC/HMBC; ** indi-
cates overlap with solvent]): 0.79 (s, H21, C3, C4, C5, C20); 0.96 (s,
H22, C7, C9, C14); 1.00 (m, H1a); 1.00 (m, H7b); 1.04 (s, H24, C1,
C5, C9, C10); 1.11 (m, H9, C12, C24); 1.40 (m, H5); 1.50 (m, H6a);
1.50 (m, H6b); 1.60–1.85 (m, H2a); 1.60–1.85 (m, H2b); 1.61(brs,
H23, C12, C13); 1.75 (m, H7a); 1.85 (m, H1b); 2.15 (m, H11b); 2.27
(brs, H6’ , C40, C50); 2.30 (m, H11a); 3.35 (m, H14); 3.67 (dd, H3, J =
5 Hz, 12 Hz); 4.04 (d, H20a, J = 11.5 Hz); 4.11 (d, H20b, J = 11.5 Hz,
C-10, C3, C5); 5.47 (brs, H12); 5.91 (d, H4’ , J = 3.5 Hz, C-20, C-30,
C-50); 5,93 (s, H16); 6.75 (d, H30, J = 3.5 Hz, C-20, C-40, C-50); 13C
NMR (CD3OD) d: 12.9 (C21); 12.9 (C6’ ); 15.3 (C24); 18.9 (C6); 22.7
(C23); 23.8 (C11); 27.6 (C2); 29 (C22*); 39.5 (C1); 40 (C14*); 40.1
(C10); 40.2 (C7); 40.2 (C8); 43 (C4*); 50 (C5**); 56 (C9*); 66.1 (C20);
72.7 (C3); 101 (C16*); 109.6 (C4’ ); 117.5 (C30); 122.0 (C12); 123.4
(C20); 136.1 (C50); 162.5 (C1’ ). Carbon signals at C13, C15, C18,
and C19 were not detectable due to low quantity.
Phenalinolactone CD6 (6)
1H NMR (CD3OD) d (multiplicity, assignment, coupling constants,
HMBCs [* indicates assignments exchangeable; ** indicates overlap
with solvent; *** indicates long-range couplings and 13C-signals
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375detectable only at 248K]): 0.78 (s, H20, C3, C4, C5, C19), 0.86 (m, H5,
C20), 0.91 (s, H21, C7, C8, C9, C14), 0.94 (s, H23, C1, C5, C9), 0.95 (m,
H7a), 0.96 (s, H19, C3, C4, C5, C20), 1.06 (brd, H9, C8, C11, C12, C21,
C23), 1.08 (m, H1a), 1.54 (brs, H22, C12, C13, C14), 1.60 (m,, H2ab),
1.60 (m, H6ab), 1.80 (m, H1b), 1.80 (m, H7b), 2.10 (brd, H11a, J = 15
Hz,), 2.20 (brd, H11b, J = 15 Hz), 3.13 (dd, H3, J = 5, 12 Hz, C20), 3.15
(brd, H14, J = 11 Hz, C16***), 5.51 (brs, H12), 6.29 (d, H16, J = 16 Hz,
C17***, C18***), 6.82 (dd, H15, J = 11, 16 Hz, C17***); 13C NMR
(CD3OD) d:15.2 (C23), 16.4 (C20), 19.0 (C6), 23.3 (C22), 23.6 (C11),
27.9 (C21), 28.1 (C2), 28.8 (C19), 37.8 (C8), 39.4 (C1), 40.0 (C4*),
40.0 (C10*), 40.3 (C7*), 50 (C14**), 56.1 (C9), 57.1 (C5), 79.7 (C3),
123.8 (C12), 132.0 (C16), 133.3 (C13), 156.0 (C15), 168.5 (C18***),
191.0 (C17***).
Phenalinolactone CD7 (7)
1H NMR (CD3OD) d (multiplicity, assignment, coupling constants
[* indicates indirectly observed through 1H, 1H-COSY; ** indicates
assignments exchangeable]): 0.80–1.80 (m, H5, H6ab, H7ab), 0.95
(s, H21**), 0.97 (s, H23**), 1.07 (s, H20**), 1.08 (s, H19**), 1.08 (m,
H1a), 1.15 (brd, H9*), 1.57 (brs, H22), 1.60 (m, H6ab), 1.80 (m, H1b),
1.80 (m, H7b), 2.10 (brd, H11a, J = 15 Hz,), 2.20 (brd, H11b), 2.49
(dd, H2ab), 3.18 (brd, H14*, J = 11 Hz), 5.53 (brs, H12), 6.32
(d, H16, J = 16 Hz), 6.82 (dd, H15, J = 11, 16 Hz).
Feeding of D-[1-13C]glucose and Quantification of Enrichment
Double-baffled Erlenmeyer flasks (3 3 2 liter), each containing 330
ml NL 19 medium (2% soy flour, 2% mannitol, pH adjusted to 7.2),
were inoculated with a 32-hr-old Streptomyces sp. Tu¨6071 seed cul-
ture. The cultures were grown in a rotary incubator at 28ºC and 180
rpm. D-[1-13C]glucose was fed in equal portions after 96, 120, 144,
and 168 hr in a total amount of 2 g/1000 ml of culture. The fermenta-
tion was harvested 8 days after inoculation. The extraction and iso-
lation of labeled phenalinolactone D was done as described above.
To quantify the relative 13C-enrichments resulting from exogenously
supplied D-[1-13C]glucose, an average normalization factor was cal-
culated from carbon resonances expected to be unlabeled. This was
done by dividing the average intensity of the selected signal from the
natural abundance spectrum by the average intensity of the same
signal from the 13C-enriched spectrum. All resonances in the 13C-en-
riched spectrum were then multiplied by this normalization value,
giving the relative enrichment.
Generation of Mutant Strains of Streptomyces sp. Tu¨6071
DNA manipulation was carried out with E. coli XL-1 Blue MRF0 (Stra-
tagene) as host strain. To generate the mutants Streptomyces sp.
Tu¨6071 DplaM1, DplaO1, DplaO4, DplaT1, DplaT2, and DplaT3 by
means of insert-directed homologous recombination, the target
genes were amplified by PCR, including flanking DNA of about 1.0
kbp up- and downstream of the start and stop codon, respectively.
Cosmids 3-1O12 and 10-4D08 were used as template. The primer
sequences and a detailed protocol for the generation of the final
plasmids are available in the Supplemental Data. The final
pKC1132-derived plasmids were introduced into Streptomyces sp.
Tu¨6071 by intergeneric conjugation with the methylation-deficient
donor strain E. coli ET12567 (dam2, dcm2, hsdS, CmR) [43] contain-
ing the conjugative vector pUZ8002 (see below). Exconjugants were
selected for the integration of the vector with apramycin. Resistant
colonies (single crossover) were grown nonselectively on HA agar
plates for several generations. Spores of single colonies were
dissected by replica plating for individuals that had lost the vector
(double crossover). Single and double crossover recombination
events were screened by PCR (see Supplemental Data).
Intergeneric Conjugation
A colony of the donor strain E. coli ET12567 (pUZ8002) containing
pKC1132-derived inactivation plasmids or pSET152 constructs for
complementation was plated out on LB agar containing chloram-
phenicol (25 mg ml21), kanamycin (30 mg ml21), and apramycin (35
mg ml21), and incubated at 37ºC overnight. Donor cells were
scratched from the abundantly covered plate and suspended in
a spore suspension of the recipient strain Streptomyces sp.
Tu¨6071 prepared with HA liquid media. The mixture was spread on
MS agar, incubated for 12–14 hr at 28ºC, and overlaid with 1 ml water
containing 0.8 mg nalidixic acid and 1.2 mg apramycin. The plates
were further incubated at 28ºC. Exconjugants were transferred onTSB agar containing nalidixic acid (35 mg ml21) and apramycin
(35 mg ml21).
Complementation of Streptomyces sp. Tu¨6071 Mutant Strains
Mutant strains were complemented with pSET152-derived con-
structs (see Supplemental Data) carrying only the target gene behind
the strong ermE promotor. The complementation plasmids were in-
troduced in the respective mutant strains by conjugation, and ex-
conjugants were selected with apramycin. Resistant colonies were
grown nonselectively and the restored wild-type production was
assessed by HPLC/MS analyses.
Supplemental Data
Supplemental Data, including information regarding vectors, PCR
conditions, and generation and complementation of mutant strains
of Streptomyces sp. Tu¨6071, are available online at http://www.
chembiol.com/cgi/content/full/13/4/365/DC1/.
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